China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Cash Flow Statement
Cash Flow Statement
China Resources Boya Bio pharmaceutical Group Co Ltd
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Cash Taxes Paid |
(40)
|
(53)
|
(60)
|
(66)
|
(71)
|
(66)
|
(71)
|
(76)
|
(84)
|
(90)
|
(94)
|
(99)
|
(107)
|
(135)
|
(154)
|
(184)
|
(229)
|
(248)
|
(260)
|
(245)
|
(230)
|
(246)
|
(242)
|
(266)
|
(250)
|
(219)
|
(216)
|
(190)
|
(184)
|
(182)
|
(176)
|
(193)
|
(222)
|
(220)
|
(247)
|
(228)
|
(210)
|
(246)
|
(232)
|
(250)
|
(227)
|
|
Change in Working Capital |
(69)
|
(66)
|
(83)
|
(129)
|
(143)
|
(168)
|
(191)
|
(177)
|
(211)
|
(259)
|
(271)
|
(283)
|
(298)
|
(304)
|
(452)
|
(470)
|
(595)
|
(702)
|
(745)
|
(933)
|
(1 021)
|
(1 133)
|
(1 319)
|
(1 278)
|
(1 255)
|
(1 244)
|
(1 106)
|
(1 181)
|
(1 181)
|
(1 178)
|
(1 142)
|
(340)
|
(334)
|
(258)
|
(226)
|
(982)
|
(910)
|
(882)
|
(862)
|
(813)
|
(752)
|
|
Cash from Operating Activities |
93
N/A
|
113
+22%
|
112
-1%
|
122
+9%
|
95
-22%
|
95
+0%
|
114
+20%
|
147
+29%
|
149
+1%
|
143
-4%
|
146
+2%
|
199
+36%
|
168
-16%
|
95
-44%
|
21
-78%
|
(24)
N/A
|
(3)
+86%
|
115
N/A
|
138
+20%
|
35
-75%
|
(34)
N/A
|
(140)
-307%
|
(286)
-104%
|
(115)
+60%
|
38
N/A
|
228
+501%
|
622
+173%
|
719
+16%
|
808
+12%
|
1 474
+82%
|
1 411
-4%
|
1 345
-5%
|
1 208
-10%
|
578
-52%
|
549
-5%
|
596
+9%
|
797
+34%
|
761
-5%
|
745
-2%
|
642
-14%
|
543
-15%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Capital Expenditures |
(31)
|
(29)
|
(39)
|
(48)
|
(90)
|
(121)
|
(146)
|
(159)
|
(172)
|
(194)
|
(214)
|
(300)
|
(311)
|
(345)
|
(348)
|
(238)
|
(227)
|
(154)
|
(116)
|
(114)
|
(75)
|
(75)
|
(84)
|
(89)
|
(98)
|
(93)
|
(88)
|
(143)
|
(138)
|
(141)
|
(130)
|
(68)
|
(56)
|
(52)
|
(90)
|
(138)
|
(149)
|
(169)
|
(136)
|
(87)
|
(85)
|
|
Other Items |
(228)
|
(241)
|
(241)
|
(87)
|
43
|
(31)
|
(31)
|
(124)
|
(172)
|
(102)
|
(122)
|
(99)
|
(51)
|
(6)
|
14
|
(132)
|
(218)
|
(1 117)
|
(1 147)
|
(96)
|
(277)
|
607
|
842
|
(185)
|
(94)
|
(194)
|
(382)
|
14
|
143
|
(700)
|
(508)
|
(2 468)
|
(3 168)
|
(2 227)
|
(2 436)
|
(422)
|
281
|
489
|
(166)
|
102
|
(109)
|
|
Cash from Investing Activities |
(260)
N/A
|
(269)
-4%
|
(279)
-4%
|
(135)
+52%
|
(48)
+64%
|
(152)
-217%
|
(177)
-17%
|
(284)
-61%
|
(344)
-21%
|
(295)
+14%
|
(336)
-14%
|
(399)
-19%
|
(362)
+9%
|
(351)
+3%
|
(333)
+5%
|
(370)
-11%
|
(445)
-20%
|
(1 271)
-185%
|
(1 263)
+1%
|
(210)
+83%
|
(352)
-68%
|
533
N/A
|
759
+42%
|
(273)
N/A
|
(191)
+30%
|
(287)
-50%
|
(470)
-64%
|
(128)
+73%
|
4
N/A
|
(841)
N/A
|
(638)
+24%
|
(2 536)
-298%
|
(3 225)
-27%
|
(2 279)
+29%
|
(2 526)
-11%
|
(560)
+78%
|
132
N/A
|
321
+144%
|
(301)
N/A
|
14
N/A
|
(195)
N/A
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
45
|
45
|
45
|
22
|
7
|
(23)
|
(23)
|
280
|
240
|
270
|
505
|
325
|
590
|
618
|
79
|
(204)
|
(388)
|
(330)
|
16
|
410
|
117
|
(25)
|
(293)
|
(713)
|
(295)
|
(239)
|
(308)
|
0
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
0
|
|
Cash Paid for Dividends |
0
|
(38)
|
(38)
|
(38)
|
(38)
|
(46)
|
(46)
|
(47)
|
(47)
|
(55)
|
(55)
|
(55)
|
(55)
|
(33)
|
(35)
|
(40)
|
(141)
|
(117)
|
(193)
|
(102)
|
(6)
|
(70)
|
(1)
|
(95)
|
(96)
|
(96)
|
(86)
|
(89)
|
(85)
|
(43)
|
(45)
|
(46)
|
(43)
|
(89)
|
(89)
|
(83)
|
0
|
(142)
|
(139)
|
(135)
|
0
|
|
Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
491
|
0
|
491
|
492
|
1
|
2
|
(0)
|
(1)
|
(1)
|
14
|
1 015
|
1 015
|
870
|
901
|
(109)
|
(299)
|
(159)
|
0
|
(95)
|
0
|
(9)
|
90
|
(11)
|
(16)
|
2 386
|
2 387
|
2 387
|
2 393
|
(2)
|
(2)
|
(3)
|
(60)
|
(102)
|
(101)
|
|
Cash from Financing Activities |
2
N/A
|
(36)
N/A
|
(36)
N/A
|
(38)
-6%
|
(38)
N/A
|
(1)
+98%
|
(1)
-63%
|
489
N/A
|
466
-5%
|
443
-5%
|
413
-7%
|
(77)
N/A
|
226
N/A
|
207
-8%
|
234
+13%
|
465
+99%
|
199
-57%
|
1 488
+649%
|
1 440
-3%
|
847
-41%
|
691
-18%
|
(567)
N/A
|
(630)
-11%
|
(238)
+62%
|
108
N/A
|
(74)
N/A
|
(116)
-55%
|
(391)
-238%
|
(808)
-107%
|
(449)
+44%
|
(300)
+33%
|
2 032
N/A
|
2 246
+11%
|
2 004
-11%
|
2 009
+0%
|
(85)
N/A
|
(107)
-26%
|
(145)
-35%
|
(199)
-38%
|
(237)
-19%
|
(214)
+10%
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Change in Cash |
(165)
N/A
|
(192)
-17%
|
(204)
-6%
|
(51)
+75%
|
9
N/A
|
(57)
N/A
|
(64)
-12%
|
352
N/A
|
271
-23%
|
290
+7%
|
224
-23%
|
(277)
N/A
|
33
N/A
|
(49)
N/A
|
(78)
-59%
|
71
N/A
|
(250)
N/A
|
332
N/A
|
314
-5%
|
672
+114%
|
305
-55%
|
(174)
N/A
|
(157)
+10%
|
(625)
-297%
|
(45)
+93%
|
(134)
-195%
|
36
N/A
|
200
+457%
|
4
-98%
|
184
+4 172%
|
473
+157%
|
841
+78%
|
229
-73%
|
302
+32%
|
31
-90%
|
(49)
N/A
|
821
N/A
|
937
+14%
|
244
-74%
|
419
+72%
|
135
-68%
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Free Cash Flow |
62
N/A
|
85
+37%
|
73
-14%
|
74
+2%
|
4
-94%
|
(26)
N/A
|
(32)
-25%
|
(12)
+61%
|
(23)
-85%
|
(51)
-123%
|
(68)
-34%
|
(101)
-48%
|
(143)
-41%
|
(251)
-75%
|
(327)
-30%
|
(262)
+20%
|
(231)
+12%
|
(40)
+83%
|
22
N/A
|
(79)
N/A
|
(110)
-39%
|
(214)
-96%
|
(369)
-72%
|
(203)
+45%
|
(60)
+71%
|
135
N/A
|
533
+297%
|
576
+8%
|
670
+16%
|
1 333
+99%
|
1 281
-4%
|
1 277
0%
|
1 152
-10%
|
525
-54%
|
459
-13%
|
458
0%
|
647
+41%
|
592
-9%
|
609
+3%
|
554
-9%
|
458
-17%
|